Ontrak, Inc. (OTRK)
NASDAQ: OTRK · IEX Real-Time Price · USD
0.333
-0.002 (-0.69%)
At close: Apr 25, 2024, 4:00 PM
0.323
-0.010 (-3.12%)
Pre-market: Apr 26, 2024, 5:47 AM EDT

Company Description

Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States.

Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need.

The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure.

The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health.

The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.

Ontrak, Inc.
Ontrak logo
Country United States
Founded 2003
Industry Health Information Services
Sector Healthcare
Employees 102
CEO Brandon H. LaVerne

Contact Details

Address:
333 S. E. 2nd Avenue, Suite 2000
Miami, Florida 33131
United States
Phone 310 444 4300
Website ontrak-inc.com

Stock Details

Ticker Symbol OTRK
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001136174
CUSIP Number 683373104
ISIN Number US6833733024
Employer ID 88-0464853
SIC Code 8090

Key Executives

Name Position
Brandon H. LaVerne Interim Chief Executive Officer and Chief Operating Officer
Mary Louise Elizabeth Osborne President and Chief Commercial Officer
James J. Park Chief Financial Officer and Principal Accounting Officer
Arik Hill Chief Information Officer
Sunmi Janicek Chief Compliance and Privacy Officer
Sandy Gyenes Senior Vice President of Human Resources
Susan E. Etzel CPA Senior Vice President of Finance and Assistant Secretary
Dr. Judith Feld M.D., M.P.H. Chief Medical Officer
Lori Wheeless Senior Vice President of Digital Services Operations
Brianna Brennan Chief Innovation Officer

Latest SEC Filings

Date Type Title
Apr 22, 2024 S-1 General form for registration of securities under the Securities Act of 1933
Apr 22, 2024 S-8 Securities to be offered to employees in employee benefit plans
Apr 16, 2024 10-K Annual Report
Apr 16, 2024 8-K Current Report
Apr 10, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Apr 8, 2024 8-K Current Report
Apr 2, 2024 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Apr 1, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Mar 28, 2024 8-K Current Report
Feb 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals